Purchase of (1R, 2R)-trans-N-Boc-1, 2 Cyclopentanediamine

Combined Synopsis/Solicitation from National Institutes of Health, solicitation 75N94025Q00201. Responses due Sep 3, 2025. NAICS 325199, No Set aside used. Listed on SAM.gov.